Metastatic renal cell carcinoma involving the left atrium and pulmonary vein is a very rare entity and has only been reported 4 times in the literature to our knowledge. This has traditionally been managed surgically but we re- port our experience with mammalian target of rapamycin (mTOR) inhibitor therapy—temsirolimus. The treatment resulted in significant regression of the tumor but more importantly, dramatically improved patient’s symptoms. - See more at: http://www.gotoper.com/publications/ajho/2017/2017nov/case-report-metastatic-renal-cell-carcinoma-invading-the-pulmonary-vein-and-left-atrium-an-extremely-rare-occurrence-treated-with-temsirolimus#sthash.oNDOU6Ie.dpuf
Published In/Presented At
Tolay, S. Gupta, R. Jumonville, A. J. (2016). Case Report: Metastatic Renal Cell Carcinoma Invading the Pulmonary Vein and Left Atrium: An Extremely Rare Occurrence Treated With Temsirolimus. American Journal of Hematology/Oncology, 12(11), 23-26.
Hematology | Medical Sciences | Medicine and Health Sciences | Oncology
Department of Medicine, Hematology-Medical Oncology Division, Hematology-Medical Oncology Division Fellows and Residents, Department of Medicine Faculty